New York 2025-2026 Regular Session

New York Senate Bill S05421

Introduced

2/21/25

Refer

2/21/25

Refer

1/7/26

Caption

Designates Xylazine as a schedule III depressant.

Latest NY S05421 Activity

View All Events: NY 2025-2026 Regular Session S05421

Companion Bills

No companion bills found.

Previously Filed As

NY SB1724

Makes xylazine a Schedule III controlled substance

NY HB1881

Adds xylazine to the list of Schedule III controlled substances

NY S2036

Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances.

NY A864

Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances.

NY S09322

Adds 7-Hydroxymitragynine, including its salts, isomers and salts of isomers, as a schedule 1 controlled substance.

NY SB465

Classifying xylazine as a schedule III controlled drug.

NY SB1553

XYLAZINE-SCHED III-PENALTIES

NY A10502

Requires polls for special town elections to open on otherwise scheduled general election days, as designated by the state board of elections.

NY S09852

Provides that when a drug is designated or rescheduled by the federal government, it shall be deemed scheduled under NYS law automatically, without further action by the commissioner.

NY HB417

Criminal Law - Schedule III Controlled Dangerous Substances - Medetomidine and Xylazine

Similar Bills

No similar bills found.